The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial

NCT ID: NCT03313895

Last Updated: 2025-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

146 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-05

Study Completion Date

2024-07-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This multi-site clinical trial occurs at the University of Minnesota and University of Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease \[AD\] signature cortical thickness, and default mode network \[DMN\]) in older adults with amnestic MCI (aMCI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Because almost all drug trials for Alzheimer's disease (AD) have failed, developing non-pharmacological interventions with strong potential to prevent or delay the onset of AD in high-risk populations (e.g., those with mild cognitive impairment \[MCI\]) is critically important. Aerobic exercise and cognitive training are 2 promising interventions for preventing AD. Aerobic exercise increases aerobic fitness, which in turn improves brain structure and function, while cognitive training improves selective neural function intensively. Hence, combined Aerobic exercise and Cognitive Training (ACT) may very well have an additive or synergistic effect on cognition by complementary strengthening of different neural functions. Few studies have tested ACT's effects, and those studies have reported discrepant findings, largely due to varying ACT programs. The purpose of this single-blinded, 2×2 factorial Phase II randomized controlled trial (RCT) is to test the efficacy and additive/synergistic effects of a 6-month combined cycling and speed of processing (SOP) training intervention on cognition and relevant mechanisms (aerobic fitness, AD signature cortical thickness, and functional connectivity in the default mode network \[DMN\]) in older adults with amnestic MCI (aMCI).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cycling Only

Moderate-intensity cycling, 3 times a week for 6 months, supervised by an exercise specialist

Group Type ACTIVE_COMPARATOR

Cycling Only

Intervention Type BEHAVIORAL

Cycling on a recumbent stationary cycle

Cognitive Training Only

Computerized cognitive training, 3 times a week for 6 months, supervised by a specialist

Group Type ACTIVE_COMPARATOR

Cognitive Training Only

Intervention Type BEHAVIORAL

Engage in cognitive training on a computer

ACT

Moderate-intensity cycling followed by computerized cognitive training, 3 times a week for 6 months, supervised by a specialist

Group Type EXPERIMENTAL

Aerobic & Cognitive Training (ACT)

Intervention Type BEHAVIORAL

ACT stands for combined aerobic exercise and cognitive training.

Stretching and Mental Stimulation Activities

Stretching and mental stimulation activities, 3 times a week for 6 months, supervised by a specialist

Group Type SHAM_COMPARATOR

Stretching and Mental Stimulating Activities

Intervention Type BEHAVIORAL

Stretching exercises and mental stimulating activities on a computer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic & Cognitive Training (ACT)

ACT stands for combined aerobic exercise and cognitive training.

Intervention Type BEHAVIORAL

Cycling Only

Cycling on a recumbent stationary cycle

Intervention Type BEHAVIORAL

Cognitive Training Only

Engage in cognitive training on a computer

Intervention Type BEHAVIORAL

Stretching and Mental Stimulating Activities

Stretching exercises and mental stimulating activities on a computer

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A clinical diagnosis of MCI
* Community-dwelling
* Age 65 years and older
* English-speaking
* Adequate visual acuity
* Verified exercise safety by medical provider
* Stable on drugs affecting cognitive and psychological status
* Verified MRI safety
* Capacity to consent

Exclusion Criteria

* Geriatric Depression Scale \< 5
* Resting heart rate (HR) ≤50 due to arrhythmia or ≥100 beats/min
* Neurological (e.g., dementia, head trauma), psychiatric (e.g., bipolar, schizophrenia, or depression), or substance dependency (alcohol or chemical dependency) in the past 5 years that are the main contributor to MCI
* Contraindications to exercise, e.g. unstable angina, recent surgery
* New symptoms or diseases that have not been evaluated by a health care provider
* Current enrollment in another intervention study related to cognitive improvement (reduce confounding effects on outcomes)
* Abnormal MRI findings
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rochester

OTHER

Sponsor Role collaborator

Mayo Clinic

OTHER

Sponsor Role collaborator

University of St Thomas

UNKNOWN

Sponsor Role collaborator

University of Minnesota

OTHER

Sponsor Role collaborator

Arizona State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fang Yu, PhD

Role: PRINCIPAL_INVESTIGATOR

Arizona State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Arizona State University

Phoenix, Arizona, United States

Site Status

Stanford University

Stanford, California, United States

Site Status

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

University of Rochester

Rochester, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Derboghossian G, Pituch K, Anthony M, Salisbury D, Lin FV, Yu F. Relationships among cardiorespiratory fitness, brain age, and neurodegeneration in older adults with amnestic mild cognitive impairment. J Alzheimers Dis. 2025 Jun;105(3):945-954. doi: 10.1177/13872877251333613. Epub 2025 Apr 22.

Reference Type DERIVED
PMID: 40262108 (View on PubMed)

Salisbury DL, Lin FV, Yu F. Testing the iMplementation Framework fOr behavioral and LIfestyLe interventions in AlZheimer's DiseasE (MOBILIZE) via the ACT randomized controlled trial. Sci Rep. 2025 Feb 13;15(1):5341. doi: 10.1038/s41598-025-88890-9.

Reference Type DERIVED
PMID: 39948366 (View on PubMed)

Li D, Mielke MM, Bell WR, Reilly C, Zhang L, Lin FV, Yu F. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial). Trials. 2020 Jan 6;21(1):19. doi: 10.1186/s13063-019-3798-1.

Reference Type DERIVED
PMID: 31907024 (View on PubMed)

Yu F, Lin FV, Salisbury DL, Shah KN, Chow L, Vock D, Nelson NW, Porsteinsson AP, Jack C Jr. Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial. Trials. 2018 Dec 22;19(1):700. doi: 10.1186/s13063-018-3054-0.

Reference Type DERIVED
PMID: 30577848 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00001135

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Combined Exercise Trial
NCT04848038 ACTIVE_NOT_RECRUITING NA